Tue.Jan 25, 2022

article thumbnail

Digital therapeutics: a new frontier of medicine

pharmaphorum

The area of digital therapeutics is growing rapidly, and in this piece Ben Hargreaves examines why this is the case, how broadly these therapies can be applied and why investment in the area is mounting. To demonstrate how quickly the digital therapeutics space is developing, it is easiest to state that the first such therapy was approved in 2018 and since that point the annual investment in the space has more than doubled in the intervening years.

111
111
article thumbnail

Here's why UnitedHealth Group's CMO says virtual care is a 'game changer' to reach underserved populations

Fierce Healthcare

Here's why UnitedHealth Group's CMO says virtual care is a 'game changer' to reach underserved populations. hlandi. Tue, 01/25/2022 - 16:19.

116
116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PolyPhotonix raises $10m to trial sleep mask for diabetic eye disease

pharmaphorum

The UK company behind a sleep mask that aims to treat sight-robbing complications of diabetes has secured $10 million in funding that will be used to run trials of the medical device. PolyPhotonix secured the money in a first-round financing led by Prevail InfoWorks, a company specialising in management of clinical trial data, with the cash injection due upon the start of a clinical trial in the US.

Hospitals 110
article thumbnail

FDA approves IND for clinical trial evaluating CBD-based drug

Outsourcing Pharma

The agency has given the go-ahead on an IND application for a study evaluating Ananda Scientificâs Nantheia ATL5, a candidate for treating opioid use disorder.

FDA 105
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Utilising real-time data to improve customer engagement

pharmaphorum

Oskar Möbert, Vice President OpenData Europe at Veeva Systems, tells us how they are reimagining customer reference data to boost pharma rep productivity, enable more personalised engagement, and increase patient reach. The medical landscape is generally becoming more complex, both in terms of the range of stakeholders involved in patient care and the rapid explosion of engagement channels. “Our customers need to make decisions based on insights powered by a deep understanding of their tar

article thumbnail

As HHS releases another $2B in COVID relief payments, hospitals call for Congress to cover delta, omicron expenses

Fierce Healthcare

As HHS releases another $2B in COVID relief payments, hospitals call for Congress to cover delta, omicron expenses. dmuoio. Tue, 01/25/2022 - 12:13.

More Trending

article thumbnail

Lawmakers, AHA urge White House to investigate nurse staffing agencies' price hikes

Fierce Healthcare

Lawmakers, AHA urge White House to investigate nurse staffing agencies' price hikes. dmuoio. Tue, 01/25/2022 - 17:18.

111
111
article thumbnail

Multi-national studies call for informed approach: Firma Clinical Research

Outsourcing Pharma

Am expert from the CRO discusses unique challenges associated with running clinical trials that stretch across national boarders and how to conquer them.

104
104
article thumbnail

Flatiron Health inks RWD partnership with Japanese cancer center to drive international expansion

Fierce Healthcare

Flatiron Health inks RWD partnership with Japanese cancer center to drive international expansion. hlandi. Tue, 01/25/2022 - 19:49.

98
article thumbnail

Understanding the prevention and treatment needs for cardiovascular disease

pharmaphorum

What does the current picture of cardiovascular disease in Europe look like? Surprisingly for many, cardiovascular disease (CVD) is Europe’s leading cause of death – not cancer, as many people would assume. Last year, over 60 million people in the EU – more than the population of Italy – were living with CVD. While there has been some progress in understanding the prevention and treatment needs for CVD, it often does not receive the attention it duly deserves.

59
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Judge lifts block preventing former ThedaCare employees from starting new roles at Ascension

Fierce Healthcare

Judge lifts block preventing former ThedaCare employees from starting new roles at Ascension. dmuoio. Tue, 01/25/2022 - 15:46.

98
article thumbnail

PharmDs – Crucial to Chronic Care Management Services: A Doctor’s Perspective

PharmD Live

PharmDs Earn MVP Status . By Marshall Eidenberg, OD. Chronic care services managed by a doctor of pharmacy, PharmD, is a critical addition to a medical practice, but they are not widely engaged with these responsibilities. With the challenging number of diagnoses and medications that Medicare patients take, it is essential to have a team member whose primary function is to rapidly review patients records, give informed advice on any side effects to watch out for, and give medication interaction

article thumbnail

Insurers missing the mark on mental health parity, new federal report says

Fierce Healthcare

Insurers missing the mark on mental health parity, new federal report says. pminemyer. Tue, 01/25/2022 - 15:01.

Insurance 105
article thumbnail

Checkpoint Therapeutics Announces Positive Topline Results from the Registration-Enabling Trial of Cosibelimab

Pharma Mirror

Waltham, Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced positive topline results from its registration-enabling clinical trial evaluating the safety and efficacy of its anti-PD-L1 antibody, cosibelimab, administered as a fixed dose of 800 mg every two weeks in patients with metastatic cutaneous squamous cell carcinoma (“cSCC”).

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Aledade taps former North Carolina HHS secretary to run its new health services unit

Fierce Healthcare

Aledade taps former North Carolina HHS secretary to run its new health services unit. hlandi. Tue, 01/25/2022 - 12:13.

98
article thumbnail

Indegene expands global operations with new nearshore centers in Americas and Europe

Pharma Mirror

PRINCETON, N.J. and BANGALORE, India, Indegene, a technology-led healthcare solutions provider today announced it established new Global Development Centers in Mexico, Poland and Ukraine to enable life sciences organizations accelerate their digital transformation. The life sciences industry is witnessing tremendous change with a growing focus on personalization, transformation of go-to-market models, and rapid adoption of real-world data and evidence to improve health outcomes.

52
article thumbnail

First telehealth-focused VC fund launches with $75M for enterprise solutions in mental health, obesity, pediatrics

Fierce Healthcare

First telehealth-focused VC fund launches with $75M for enterprise solutions in mental health, obesity, pediatrics. rtorrence. Tue, 01/25/2022 - 14:38.

64
article thumbnail

Billionaire Mark Cuban steps up assault on US medicine prices

pharmaphorum

Mark Cuban, billionaire owner of the Dallas Mavericks basketball team, just got involved in the online pharmacy business, promising to “shield consumers from inflated drug prices.” The online pharmacy launch comes a few weeks after Cuban set up a pharmacy benefit manager (PBM) operation – the Mark Cuban Cost Plus Drug Company (MCCPDC) – promising to cut out the middleman in the medicines supply chain so it can eliminate markups on generic drugs and pass savings on to its customers.

article thumbnail

Change Healthcare mulling sale of its ClaimsXten arm to secure federal OK for UnitedHealth merger

Fierce Healthcare

Change Healthcare mulling sale of its ClaimsXten arm to secure federal OK for UnitedHealth merger. pminemyer. Tue, 01/25/2022 - 17:32.

52
article thumbnail

FDA stifles Merck’s cough drug gefapixant, asking for more data

pharmaphorum

The FDA has issued a complete response letter (CRL) to Merck & Co’s gefapixant candidate for refractory chronic cough, delaying the programme and giving Bayer an opportunity to close the gap with its rival eliapixant drug. Gefapixant is still out in front in the non-narcotic, orally administered selective P2X3 receptor antagonist class – having secured a first regulatory approval in Japan as Lyfnua last week – but the FDA’s decision could threaten its chances of being first to ma

FDA 52
article thumbnail

Atlas Health banks $40M in latest funding round to expand software, sales team

Fierce Healthcare

Atlas Health banks $40M in latest funding round to expand software, sales team. agliadkovskaya. Tue, 01/25/2022 - 16:35.

52
article thumbnail

BenchSci raises $50m to grow AI-powered R&D platform

pharmaphorum

Canadian firm BenchSci has secured around $50 million in third-round financing that will be used to speed up the adoption of its artificial intelligence-powered platform for biomedical research internationally. The Toronto-based company already counts many of the world’s largest pharma companies among its customers, using its platform for a range of tasks such as improving reagent and antibody selection to help scientists run more successful experiments, drawing on data from published stud

52
article thumbnail

Engaging Oncologists in 2022

Pharma Marketing Network

The post Engaging Oncologists in 2022 appeared first on Pharma Marketing Network.

52
article thumbnail

Innovative phase 2 trial targets advanced liver cancer

Pharma Times

The UCL study will evaluate the safety and effectiveness of MTL-CEBPA in combination with second line standard of care sorafenib versus the use of sorafenib in isolation

49
article thumbnail

Pfizer starts dosing patients with its Omicron COVID shot

pharmaphorum

Pfizer and partner BioNTech have started their clinical trial of a new version of their COVID-19 vaccine that has been specifically designed to protect against the Omicron variant. The trial in 1,420 adult patients aged 18 to 55 will include dosing with the partners’ existing Comirnaty mRNA-based vaccine with the Omicron-based jab in a mix-and-match approach that will be used to determine the best combination.

article thumbnail

Access to Novartis treatment for Myeloid leukaemia patients

Pharma Times

Novartis UK has announced that the MHRA has given a positive scientific opinion for the investigational treatment, asciminib

46